RVPH

0.313010.21%
PP

Parag Phoolchand Saxena

Independent Chairman of the Board

Mr. Parag Phoolchand Saxena, M.B.A., M.S., is Director of CereSpir Incorporated. Mr. Saxena Serves as Advisor at SetuServ, Inc. He has been the Independent Chairman of the Board at Reviva Pharmaceuticals Holdings, Inc. since December 2020. Mr. Saxena is the Founding General Partner and Chief Executive Officer at Rivendell PE LLC. He is Director at Tauc3 Biologics Limited. Mr. Saxena serveD as Chairman of the Board at Tenzing Acquisition Corp. since 2018 UNTIL 2020. Mr. Saxena serves as Co-Founder & Managing Partner at Vedanta Capital LP. He was General Partner of Vedanta Capital LP. Mr. Saxena co-founded Vedanta Management LP and NSR Advisors in 2006 and serves as the Managing Partner and Chief Executive Officer. Mr. Saxena is the Co-Founder of South Asian American Forum. He was the Co-Founder of INVESCO Partnership Fund, II, IV, V, L.P. and served as Chief Executive Officer & Managing Partner. He has extensive investment experience in the U.S. and in the Indian subcontinent. He served as the Chief Executive Officer of Vedanta Capital, LLC. He founded Vedanta Capital in 2006. He served as the President of Tri-state at The Indus Entrepreneurs. Mr. Saxena served as Managing Partner and Chief Executive Officer of INVESCO Private Capital (IPC), where he was responsible for both direct and fund of funds investment activities. During his tenure, over 300 investments were made, including Amgen, Costco, PictureTel, Polycom, Staples and Starbucks. He has also led more than 90 investments for Chancellor and INVESCO Private Capital. These investments include Amber Networks, Masimo, Alkermes, Celgene, Genomic Health, Transgenomic, Xenon Pharmaceuticals, ARM Holdings, Indigo, MetroPCS and Volterra. He began his career in 1978 at Becton Dickinson as a Product Manager. He was the President of TiE Tri-State from 2003 to 2010. He has provided recommendations on small business and venture capital to Representatives of the U.S. Congress. He is a Director of The Indus Entrepreneurs (TiE), Post-Hypothermia Corporation and Coffee Day Hotels & Resorts Pvt.Ltd. Mr. Saxena has been a Director of POINT Biomedical Corp. since 2007. He was also a Director of the Indian Institute of Technology, Bombay’s Heritage Fund as well as a Trustee of the Bharatiya Vidya Bhavan. He serves as on the Advisory Board of the Center for Advanced Studies on India at the University of Pennsylvania and is on the Indian Advisory Council of Brown University. He is the Co-Owner at Tenzing LLC. Mr. Saxena served as a Director at Ascend Telecom Infrastructure Pvt. Ltd until March 23, 2022. He serves as a Director of Augere Holdings (Netherlands) B.V. He served as a Director of Transgenomic Inc., since 1999 until March 16, 2007. He served as a Director of DiscoverX Corporation and SkyPilot Networks Inc. He served as a Director of Post-Hypothermia Corporation. He served as a Director at ENDFORCE, Inc. He served as a Director of Quadrant Televentures Ltd since April 29, 2003 until April 9, 2010. He served as a Director of Cellzome AG. He served as a Director of Cyclacel Pharmaceuticals, Inc. until 2004 and Genomic Health Inc. since February 2003. He served as a Director of Xenon Pharmaceuticals Inc. since June 2001. He served as Director at Genomic Health, Inc. since Feb 2003. He served as a Director of GovXcel, Health Grades, Inc., EluSys Therapeutics Inc., Genomics Collaborative, Inc. and Amber Networks, Inc. He was a Director of BlackHog, Inc. He served as Director at Healthgrades Operating Company, Inc. He served as a Director of Coffee Day Enterprises Limited until May 5, 2015. He is registered with the NASD as a General Securities Representative (Series 7). He was named to the Forbes Midas List of the Top 100 Deal Makers in January 2009. His deep financial, entrepreneurial and business expertise. He is the majority owner and controls Vedanta Partners, LLC. He has also been appointed to Brown University's Advisory Council on Biology and Medicine. He also serves on the Board of the Windreich Department of Artificial Intelligence and Human Health at Mount Sinai Health System. Mr. Saxena received M.B.A. from the Wharton School of the University of Pennsylvania in 1982, M.S. Degree in Chemical Engineering from the West Virginia College of Graduate Studies in 1978 and a B.Tech. from the Indian Institute of Technology, Bombay in 1977.

Positions